cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing

Virology

Volumn 323, Issue 1, 2004, Pages 131-140

  Liao, Huey Jane ^a   Baker, Carl C ^b   Princler, Gerald L ^c   Derse, David ^c  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

EIAV; Purine rich element; Splicing

Indexed keywords

CIS ACTING ELEMENT; TRANS ACTING FACTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXON; GENE CONSTRUCT; GENE CONTROL; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HORSE DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROVIRUS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; WILD TYPE;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; ENHANCER ELEMENTS (GENETICS); EXONS; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; INFECTIOUS ANEMIA VIRUS, EQUINE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PURINES; RNA PRECURSORS; RNA, MESSENGER;

ANIMALIA; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUUS CABALLUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; RNA VIRUSES;

EID: 2542426491     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.12.028     Document Type: Article

References (43)

1. Amendt B.A., Hesslein D., Chang L.J., Stoltzfus C.M. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 14(6):1994;3960-3970
2. Amendt B.A., Si Z.H., Stoltzfus C.M. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell. Biol. 15(8):1995;4606-4615
3. Belshan M., Park G.S., Bilodeau P., Stoltzfus C.M., Carpenter S. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs. Mol. Cell. Biol. 20(10):2000;3550-3557
4. Bilodeau P.S., Domsic J.K., Mayeda A., Krainer A.R., Stoltzfus C.M. RNA splicing at human immunodeficiency virus type 1 3′ splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. J. Virol. 75(18):2001;8487-8497
5. Blanchette M., Chabot B. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J. 18(7):1999;1939-1952
6. Burd C.G., Dreyfuss G. RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J. 13(5):1994;1197-1204
7. Caceres J.F., Stamm S., Helfman D.M., Krainer A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science. 265(5179):1994;1706-1709
8. Caputi M., Mayeda A., Krainer A.R., Zahler A.M. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J. 18(14):1999;4060- 4067
9. Chung H., Derse D. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA. J. Biol. Chem. 276(22):2001;18960-18967
10. Damgaard C.K., Tange T.O., Kjems J. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure. RNA. 8(11):2002;1401-1415
11. Del Gatto-Konczak F., Olive M., Gesnel M.C., Breathnach R. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol. Cell. Biol. 19(1):1999;251-260
12. Fu X.D. The superfamily of arginine/serine-rich splicing factors. RNA. 1(7):1995;663-680
13. Garcia-Blanco M.A., Jamison S.F., Sharp P.A. Identification and purification of a 62, 000-dalton protein that binds specifically to the polypyrimidine tract of introns. Genes Dev. 3(12A):1989;1874-1886
14. Gontarek R.R., Derse D. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. Mol. Cell. Biol. 16(5):1996;2325-2331
15. Graveley B.R. Sorting out the complexity of SR protein functions. RNA. 6(9):2000;1197-1211
16. Harris M.E., Hope T.J. RNA export: insights from viral models. Essays Biochem. 36:2000;115-127
17. Harris M.E., Gontarek R.R., Derse D., Hope T.J. Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein. Mol. Cell. Biol. 18(7):1998;3889-3899
18. Hoffman B.E., Grabowski P.J. U1 snRNP targets an essential splicing factor, U2AF65, to the 3′ splice site by a network of interactions spanning the exon. Genes Dev. 6(12B):1992;2554-2568
19. Jacquenet S., Mereau A., Bilodeau P.S., Damier L., Stoltzfus C.M., Branlant C. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J. Biol. Chem. 276(44):2001;40464-40475
20. Kuo H.C., Nasim F.H., Grabowski P.J. Control of alternative splicing by the differential binding of U1 small nuclear ribonucleoprotein particle. Science. 251(4997):1991;1045-1050
21. Ladd A.N., Cooper T.A. Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol. 3(11):2002;. (reviews0008)
22. Martarano L., Stephens R., Rice N., Derse D. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing. J. Virol. 68(5):1994;3102-3111
23. Mayeda A., Krainer A.R. Mammalian in vitro splicing assays. Methods Mol. Biol. 118:1999;315-321
24. Mayeda A., Krainer A.R. Preparation of HeLa cell nuclear and cytosolic S100 extracts for in vitro splicing. Methods Mol. Biol. 118:1999;309-314
25. Merendino L., Guth S., Bilbao D., Martinez C., Valcarcel J. Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3′ splice site AG. Nature. 402(6763):1999;838-841
26. Noble J.C., Prives C., Manley J.L. Alternative splicing of SV40 early pre-mRNA is determined by branch site selection. Genes Dev. 2(11):1988;1460-1475
27. Reed R., Maniatis T. Intron sequences involved in lariat formation during pre-mRNA splicing. Cell. 41(1):1985;95-105
28. Reed R., Maniatis T. The role of the mammalian branchpoint sequence in pre-mRNA splicing. Genes Dev. 2(10):1988;1268-1276
29. Schaal T.D., Maniatis T. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences. Mol. Cell. Biol. 19(3):1999;1705-1719
30. Stephens R.M., Derse D., Rice N.R. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins. J. Virol. 64(8):1990;3716-3725
31. Sun Q., Mayeda A., Hampson R.K., Krainer A.R., Rottman F.M. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7(12B):1993;2598-2608
32. Tacke R., Manley J.L. Determinants of SR protein specificity. Curr. Opin. Cell Biol. 11(3):1999;358-362
33. Tange T.O., Kjems J. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain. J. Mol. Biol. 312(4):2001;649-662
34. Tange T.O., Damgaard C.K., Guth S., Valcarcel J., Kjems J. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J. 20(20):2001;5748-5758
35. Vogel J., Hess W.R., Borner T. Precise branch point mapping and quantification of splicing intermediates. Nucleic Acids Res. 25(10):1997;2030-2031
36. Wodrich H., Krausslich H.G. Nucleocytoplasmic RNA transport in retroviral replication. Results Probl. Cell Differ. 34:2001;197-217
37. Wu J., Manley J.L. Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing. Genes Dev. 3(10):1989;1553-1561
38. Wu S., Romfo C.M., Nilsen T.W., Green M.R. Functional recognition of the 3′ splice site AG by the splicing factor U2AF35. Nature. 402(6763):1999;832-835
39. Zahler A.M., Lane W.S., Stolk J.A., Roth M.B. SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev. 6(5):1992;837-847
40. Zamore P.D., Patton J.G., Green M.R. Cloning and domain structure of the mammalian splicing factor U2AF. Nature. 355(6361):1992;609-614
41. Zheng Z.M., Baker C.C. Parameters that affect in vitro splicing of bovine papillomavirus type 1 late pre-mRNAs. J. Virol. Methods. 85(1-2):2000;203-214
42. Zhuang Y., Weiner A.M. A compensatory base change in human U2 snRNA can suppress a branch site mutation. Genes Dev. 3(10):1989;1545-1552
43. Zorio D.A., Blumenthal T. Both subunits of U2AF recognize the 3′ splice site in Caenorhabditis elegans. Nature. 402(6763):1999;835-838